Rhythm Pharmaceuticals (RYTM) PT Raised to $40 at Wells Fargo
Tweet
Share
E-mailGet Alerts RYTM Hot Sheet
Price: $108.92 --0%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $40.00 (from $38.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- HomeTrust Bancshares (HTB) PT Raised to $57 at Stephens
- LY Corporation (4689:JP) (YAHOY) PT Raised to JPY750 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
